These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 31567652)
1. A high-dose rapamycin treatment alleviates hepatopulmonary syndrome in cirrhotic rats. Chang CC; Chuang CL; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD J Chin Med Assoc; 2020 Jan; 83(1):32-40. PubMed ID: 31567652 [TBL] [Abstract][Full Text] [Related]
2. Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats. Chang CC; Lee WS; Hsieh HG; Chuang CL; Huang HC; Lee FY; Lee SD PLoS One; 2017; 12(6):e0179809. PubMed ID: 28632747 [TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung. Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601 [TBL] [Abstract][Full Text] [Related]
4. The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome. Cheng TY; Lee WS; Huang HC; Lee FY; Chang CC; Lin HC; Lee SD J Chin Med Assoc; 2017 Nov; 80(11):683-689. PubMed ID: 28969989 [TBL] [Abstract][Full Text] [Related]
5. Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats. Chang CC; Chuang CL; Tsai MH; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925782 [TBL] [Abstract][Full Text] [Related]
6. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. Chang CC; Chuang CL; Lee FY; Wang SS; Lin HC; Huang HC; Teng TH; Hsu SJ; Hsieh HG; Lee SD Clin Sci (Lond); 2013 Apr; 124(7):457-66. PubMed ID: 23043394 [TBL] [Abstract][Full Text] [Related]
7. Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat. Mangoura SA; Ahmed MA; Hamad N; Zaka AZ; Khalaf KA; Mahdy MA Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102408. PubMed ID: 38925324 [TBL] [Abstract][Full Text] [Related]
8. Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats. Ko MT; Huang HC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD J Chin Med Assoc; 2017 Aug; 80(8):467-475. PubMed ID: 28676445 [TBL] [Abstract][Full Text] [Related]
9. TNF-α neutralization improves experimental hepatopulmonary syndrome in rats. Liu L; Liu N; Zhao Z; Liu J; Feng Y; Jiang H; Han D Liver Int; 2012 Jul; 32(6):1018-26. PubMed ID: 22672643 [TBL] [Abstract][Full Text] [Related]
10. Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Li X; Chen Y; Wang L; Shang G; Zhang C; Zhao Z; Zhang H; Liu A Braz J Med Biol Res; 2016 Jul; 49(7):. PubMed ID: 27383124 [TBL] [Abstract][Full Text] [Related]
11. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling. Zhu J; Qiu J; Chen K; Wang W; Zheng S Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Zhang J; Luo B; Tang L; Wang Y; Stockard CR; Kadish I; Van Groen T; Grizzle WE; Ponnazhagan S; Fallon MB Gastroenterology; 2009 Mar; 136(3):1070-80. PubMed ID: 19109954 [TBL] [Abstract][Full Text] [Related]
13. Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. Baweja S; Kumari A; Negi P; Tomar A; Tripathi DM; Mourya AK; Rastogi A; Subudhi PD; Thangariyal S; Kumar G; Kumar J; Reddy GS; Sood AK; Vashistha C; Sarohi V; Bihari C; Maiwall R; Sarin SK J Hepatol; 2023 Jul; 79(1):167-180. PubMed ID: 36996943 [TBL] [Abstract][Full Text] [Related]
14. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346 [TBL] [Abstract][Full Text] [Related]
15. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome. Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956 [TBL] [Abstract][Full Text] [Related]
16. Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways. Bakr AG; El-Bahrawy AH; Taha HH; Ali FEM Eur J Pharmacol; 2020 Apr; 873():173008. PubMed ID: 32050083 [TBL] [Abstract][Full Text] [Related]
17. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Thenappan T; Goel A; Marsboom G; Fang YH; Toth PT; Zhang HJ; Kajimoto H; Hong Z; Paul J; Wietholt C; Pogoriler J; Piao L; Rehman J; Archer SL Am J Respir Crit Care Med; 2011 Apr; 183(8):1080-91. PubMed ID: 21148721 [TBL] [Abstract][Full Text] [Related]
18. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury. Chen B; Ning JL; Gu JT; Cui J; Yang Y; Wang Z; Zeng J; Yi B; Lu KZ Liver Int; 2015 Apr; 35(4):1373-82. PubMed ID: 25113058 [TBL] [Abstract][Full Text] [Related]
19. Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2. Wang W; Yan J; Wang H; Shi M; Zhang M; Yang W; Peng C; Li H PLoS One; 2014; 9(1):e83908. PubMed ID: 24404143 [TBL] [Abstract][Full Text] [Related]
20. CXCR2 is involved in pulmonary intravascular macrophage accumulation and angiogenesis in a rat model of hepatopulmonary syndrome. Li X; Chen Y; Chang Y; Li S; Zhao Z; Zhang H Clin Sci (Lond); 2017 Jan; 131(2):159-168. PubMed ID: 27879294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]